Literature DB >> 17508319

Diagnostic stability 2 years after treatment initiation in the early psychosis intervention programme in Singapore.

Mythily Subramaniam1, Elaine Pek, Swapna Verma, Yiong Huak Chan, Siow Ann Chong.   

Abstract

OBJECTIVE: To evaluate the diagnostic stability of psychotic disorders over a 2 year period in patients presenting with first-episode psychosis.
METHODS: One hundred and fifty-four patients were recruited from an early psychosis intervention programme (EPIP). They were diagnosed by the attending psychiatrist using the Structured Clinical Interview for DSM-IV Axis I at first contact (baseline) and after 24 months. The diagnoses were classified into the following categories: schizophrenia spectrum disorders (schizophrenia, schizophreniform disorder and schizoaffective disorder), affective psychosis (bipolar and major depressive disorders with psychotic symptoms), and other non-affective psychosis (delusional disorder, psychosis not otherwise specified and brief psychotic disorder). Two measures of stability, the prospective and the retrospective consistency were determined for each diagnosis.
RESULTS: The diagnoses with the best prospective consistency were schizophrenia (87.0%) and affective psychosis (54.5%). The shift into schizophrenia spectrum disorder was the most frequent diagnostic change. Duration of untreated psychosis was found to be the only significant predictor of shift.
CONCLUSION: It is difficult to make a definitive diagnosis at first contact. The clinical need to review the diagnosis throughout the period of follow up is emphasized.

Entities:  

Mesh:

Year:  2007        PMID: 17508319     DOI: 10.1080/00048670701332276

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  8 in total

1.  McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients.

Authors:  Paola Salvatore; Ross J Baldessarini; Mauricio Tohen; Hari-Mandir K Khalsa; Jesus Perez Sanchez-Toledo; Carlos A Zarate; Eduard Vieta; Carlo Maggini
Journal:  J Clin Psychiatry       Date:  2010-07-13       Impact factor: 4.384

2.  Physical healthcare of people with severe mental illness: everybody's business!

Authors:  Kamini Vasudev; Brian V Martindale
Journal:  Ment Health Fam Med       Date:  2010-06

3.  Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study.

Authors:  Ditte L Vernal; Sandeep Kapoor; Aseel Al-Jadiri; Eva M Sheridan; Yehonathan Borenstein; Charles Mormando; Lisa David; Sukhbir Singh; Andrew J Seidman; Maren Carbon; Miriam Gerstenberg; Ema Saito; John M Kane; Hans-Christoph Steinhausen; Christoph U Correll
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-09       Impact factor: 2.576

4.  Prodromal research: Public health initiatives for prevention of schizophrenia.

Authors:  Amresh Shrivastava
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

5.  Evaluation of Four-Year Stability of Unspecified Psychosis.

Authors:  Halil İbrahim Taş; Merve Çelik; Kürşat Altinbaş
Journal:  Noro Psikiyatr Ars       Date:  2018-09-17       Impact factor: 1.339

6.  Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis.

Authors:  Paolo Fusar-Poli; Marco Cappucciati; Grazia Rutigliano; Margaret Heslin; Daniel Stahl; Zera Brittenden; Edgardo Caverzasi; Philip McGuire; William T Carpenter
Journal:  Schizophr Bull       Date:  2016-03-15       Impact factor: 9.306

7.  Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Benjamin Murrie; Julia Lappin; Matthew Large; Grant Sara
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

8.  Clinical characterization of brief psychotic disorders triggered by the COVID-19 pandemic: a multicenter observational study.

Authors:  María José Valdés-Florido; Álvaro López-Díaz; Fernanda Jazmín Palermo-Zeballos; Nathalia Garrido-Torres; Paula Álvarez-Gil; Iván Martínez-Molina; Victoria Eugenia Martín-Gil; Elena Ruiz-Ruiz; Macarena Mota-Molina; María Paz Algarín-Moriana; Antonio Hipólito Guzmán-Del Castillo; Ángela Ruiz-Arcos; Rafael Gómez-Coronado; Sara Galiano-Rus; Alfonso Rosa-Ruiz; Juan Luis Prados-Ojeda; Luis Gutierrez-Rojas; Benedicto Crespo-Facorro; Miguel Ruiz-Veguilla
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-04-03       Impact factor: 5.270

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.